Evidence map›Paper›PMID 41834980›Full record

ReviewSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026

[Research on Bacteriophage Resistance: Coevolutionary Arms Race Between Bacteria and Phages Drives Novel Antibacterial Therapies].

Rou Li, Fang Wan, Jixia Wei, Yajin Wen, Panhong Jia, Ping Lin, Lin Liu, Min Wu

Abstract readReviewEnglish Abstract
In one paragraph

Review in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rou Li( 550025)Medical School , Guizhou University, Guiyang 550025, China.ORCID 0000-0002-9024-8266
Fang Wan( 550025)Medical School , Guizhou University, Guiyang 550025, China.
Jixia Wei( 550025)Medical School , Guizhou University, Guiyang 550025, China.
Yajin Wen( 550025)Medical School , Guizhou University, Guiyang 550025, China.
Panhong Jia( 550025)Medical School , Guizhou University, Guiyang 550025, China.
Ping Lin( 550025)Medical School , Guizhou University, Guiyang 550025, China.
Lin Liu( 550025)Medical School , Guizhou University, Guiyang 550025, China.ORCID 0000-0002-1947-0809
Min Wu( 550025)Medical School , Guizhou University, Guiyang 550025, China.ORCID 0000-0003-1205-982X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing threat of antimicrobial resistance requires the urgent development of new therapeutic strategies and agents. Bacteriophage therapy offers a promising alternative, utilizing phages' ability to specifically recognize and lyse bacterial cells. The ubiquity of bacteriophages subjects bacteria to constant evolutionary pressure, driving the emergence of diverse systems that defend against phage infection. The repertoire of phage defense genes includes a wide range of functions, such as nucleases, helicases, and ATPases. Host-phage interactions are complex and multifaceted. Bacterial defense mechanisms operate at various levels: initial innate defenses that inhibit phage adsorption, block nucleic acid injection, and interfere with virion assembly; early vesicle rupture targeting phage nucleic acids; systems that specifically target phage DNA and RNA; and abortive infection, which results in the degradation of bacterial nucleic acids, depletion of NAD

Indexed as

BacteriaBacterial InfectionsBacteriophagesPhage TherapyAnti-Bacterial AgentsHost-Pathogen InteractionsHumansAnti-Bacterial AgentsAbortive infectionBacteriaBacteriophagesDefense systemsInfectionReview

Identifiers

PMID41834980
PMCPMC12979995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.